Notice of Closed Meeting, 66727 [2024-18434]
Download as PDF
<![CDATA[
66727
Federal Register / Vol. 89, No. 159 / Friday, August 16, 2024 / Notices
the goal and mission of the program has
evolved with each funding cycle. The
2021–2024 funding cycle is the first
such initiative to focus on addressing
health equity specifically and
understanding efforts to impact stroke
outcomes for those at highest risk of
stroke. CDC proposes to continue
collecting information from thirteen
funded PCNASP recipients to gain
insight into the effectiveness of
implementation approaches, including
linking and using data, using teambased
approaches to coordinate stroke care,
and providing community resources in
order to reach the general population
and those at highest risk of stroke
events, and reduce disparities in access
to quality care for high burden
populations. The insights to be gained
from this continuing data collection will
be critical to improving immediate
efforts and achieving the goals of
spreading and replicating State-level
strategies that are proven
programmatically and are cost-effective
in contributing to a higher quality of
care for stroke patients.
CDC requests OMB approval for an
estimated 501 annual burden hours.
There is no cost to respondents other
than their time to participate.
ESTIMATED ANNUALIZED BURDEN (HOURS)
Type of respondents
Form name
PCNASP Awardee ...........................
Pre-Hospital data ..........................................................
PCNASP Hospital Partners ..............
In-Hospital data .............................................................
Hospital Inventory (awardees) ......................................
Hospital Inventory for Hospital Partners .......................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–18374 Filed 8–15–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
In accordance with 5 U.S.C. 1009(d),
the Centers for Disease Control and
Prevention (CDC) announces the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463.
Name of Committee: Safety and
Occupational Health Study Section
(SOHSS), National Institute for
Occupational Safety and Health
(NIOSH).
Dates: October 23–24, 2024.
Times: 11 a.m.–5 p.m., EDT.
Place: Teleconference.
Agenda: The meeting will convene to
address matters related to the conduct of
Study Section business and for the
Study Section to consider safety and
occupational health-related grant
applications.
VerDate Sep<11>2014
17:33 Aug 15, 2024
Jkt 262001
For Further Information Contact:
Michael Goldcamp, Ph.D., Scientific
Review Officer, Office of Extramural
Programs, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1095 Willowdale Road, Morgantown,
West Virginia 26505. Telephone: (304)
285–5951; Email: MGoldcamp@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–18434 Filed 8–15–24; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
3
10
13
13
650
Number of
responses per
respondent
Average
burden
per
response
(in hours)
4
4
4
1
1
30/60
1
30/60
8
30/60
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–D–0055]
Voluntary Sodium Reduction Goals:
Target Mean and Upper Bound
Concentrations for Sodium in
Commercially Processed, Packaged,
and Prepared Foods; Draft Guidance
for Industry (Edition 2); Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or we) is
announcing the availability of a draft
guidance for industry entitled
‘‘Voluntary Sodium Reduction Goals:
Target Mean and Upper Bound
Concentrations for Sodium in
Commercially Processed, Packaged, and
Prepared Foods (Edition 2).’’ The draft
guidance, when finalized, will describe
our views on the next voluntary goals
(Phase II (3-year)) for sodium reduction
in a variety of identified categories of
foods that are commercially processed,
packaged, or prepared. These goals are
intended to address the excessive intake
of sodium in the current population to
help reduce the burden of diet-related
chronic disease, promote improvements
in public health, and advance health
equity by supporting a healthier food
supply.
DATES: Submit either electronic or
written comments on the draft guidance
by November 14, 2024 to ensure that we
consider your comment on the draft
SUMMARY:
E:\FR\FM\16AUN1.SGM
16AUN1
]]>Agencies
[Federal Register Volume 89, Number 159 (Friday, August 16, 2024)]
[Notices]
[Page 66727]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-18434]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
In accordance with 5 U.S.C. 1009(d), the Centers for Disease
Control and Prevention (CDC) announces the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended, and the Determination of the Director, Office of
Strategic Business Initiatives, Office of the Chief Operating Officer,
CDC, pursuant to Public Law 92-463.
Name of Committee: Safety and Occupational Health Study Section
(SOHSS), National Institute for Occupational Safety and Health (NIOSH).
Dates: October 23-24, 2024.
Times: 11 a.m.-5 p.m., EDT.
Place: Teleconference.
Agenda: The meeting will convene to address matters related to the
conduct of Study Section business and for the Study Section to consider
safety and occupational health-related grant applications.
For Further Information Contact: Michael Goldcamp, Ph.D.,
Scientific Review Officer, Office of Extramural Programs, National
Institute for Occupational Safety and Health, Centers for Disease
Control and Prevention, 1095 Willowdale Road, Morgantown, West Virginia
26505. Telephone: (304) 285-5951; Email: [email protected].
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-18434 Filed 8-15-24; 8:45 am]
BILLING CODE 4163-18-P
